Ms. Ivana Maric reports

AVICANNA ANNOUNCES CHANGES OF AUDITORS

Avicanna Inc. is changing auditors from Kingston Ross Pasnak LLP to Ramirez Jimenez International CPAs effective Aug. 2, 2024, until the next annual general meeting of shareholders of the company.

There have been no reservations or modified opinions contained in the former auditor's reports on any of the company's audited financial statements; and, there are no reportable events including disagreements, consultations or unresolved issues as defined in National Instrument 51-102 -- Continuous Disclosure Obligations (Part 4.11) between the company and the former auditor, during the period that the former auditor acted as the company's auditor. In accordance with NI 51-102, the notice of change of auditors, together with the required letters from the former auditor and the successor auditor, have been reviewed by the audit committee and board of directors and filed on SEDAR+.

About Avicanna Inc.

Avicanna is a commercial-stage international biopharmaceutical company focused on the advancement and commercialization of cannabinoid-based products and formulations for the global medical and pharmaceutical market segments. Avicanna has an established scientific platform including research and development, and clinical development leading to the commercialization of more than 30 proprietary, evidence-based finished products and supporting four commercial stage business pillars. One of these, medical cannabis formulary (RHO Phyto), offers a diverse range of proprietary products including oral, sublingual, topical and transdermal deliveries with varying ratios of cannabinoids, supported by patient and medical community education. RHO Phyto is an established leading medical brand in Canada currently available nationwide to patients across several medical channels and continues to expand into new international markets.

We seek Safe Harbor.